Strong Financial Performance
Operating revenue for the half was $951 million, up 18% from the prior period, with net profit after tax rising 43% to $153 million.
Successful Product Launches
Launch of the 950 system and Airvo 3 in the US added momentum to the hospital business. The new Optiflow Duet cannula has been released in major markets.
Expansion in Homecare
Homecare operating revenue was up 14% to $359 million, with the Nova Micro mask and F&P Solo gaining positive feedback.
Operational Efficiency
Gross margin improved to 61.9%, up 141 basis points, due to overhead efficiency and continued work on efficiency and margin improvements.
New Manufacturing Site
The Guangzhou manufacturing site is now operational, following regulatory clearance, expanding production capacity.